Severe Acute Respiratory Syndrome Coronavirus Infection in Vaccinated Ferrets
Open Access
- 1 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (9), 1329-1338
- https://doi.org/10.1086/522431
Abstract
Background. Development of vaccines to prevent severe acute respiratory syndrome (SARS) is limited by the lack of well-characterized animal models. PKeywords
This publication has 24 references indexed in Scilit:
- Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike VariantsPLoS Medicine, 2006
- Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infectionsCurrent Opinion in Infectious Diseases, 2006
- Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus ImmunizationJournal of Virology, 2005
- SARS Vaccine Protective in MiceEmerging Infectious Diseases, 2005
- Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoproteinVirology, 2005
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProceedings of the National Academy of Sciences, 2004
- Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of MiceJournal of Virology, 2004
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesHepatology, 2004
- Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysisWorld Journal of Gastroenterology, 2004
- SARS virus infection of cats and ferretsNature, 2003